Keywords: s-p, sales, growth, driven, claritin, schering-plough, third-quarter

S-P sales growth driven by Claritin

Article | 24 October 2000

• Print This

Schering-Plough's third-quarter 2000 net income rose 12.3% to $591million, or $0.40 per share (+14%), as sales increased 7% to $2.39 billion. Worldwide pharmaceutical sales rose 8% to $2.06 ...

Enjoying this article? To continue reading you need to login or subscribe.